These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 29287259

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Quality-by-design case study: investigation of the role of poloxamer in immediate-release tablets by experimental design and multivariate data analysis.
    Kaul G, Huang J, Chatlapalli R, Ghosh K, Nagi A.
    AAPS PharmSciTech; 2011 Dec; 12(4):1064-76. PubMed ID: 21861241
    [Abstract] [Full Text] [Related]

  • 3. Disintegration of highly soluble immediate release tablets: a surrogate for dissolution.
    Gupta A, Hunt RL, Shah RB, Sayeed VA, Khan MA.
    AAPS PharmSciTech; 2009 Dec; 10(2):495-9. PubMed ID: 19387843
    [Abstract] [Full Text] [Related]

  • 4. Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models.
    Uebbing L, Klumpp L, Webster GK, Löbenberg R.
    Drug Des Devel Ther; 2017 Dec; 11():1163-1174. PubMed ID: 28442890
    [Abstract] [Full Text] [Related]

  • 5. Investigation of an artificial intelligence technology--Model trees. Novel applications for an immediate release tablet formulation database.
    Shao Q, Rowe RC, York P.
    Eur J Pharm Sci; 2007 Jun; 31(2):137-44. PubMed ID: 17452096
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The sound of tablets during coating erosion, disintegration, deaggregation and dissolution.
    O'Mahoney N, Keating JJ, McSweeney S, Hill S, Lawrence S, Fitzpatrick D.
    Int J Pharm; 2020 Apr 30; 580():119216. PubMed ID: 32165222
    [Abstract] [Full Text] [Related]

  • 8. New designed special cells for Raman mapping of the disintegration process of pharmaceutical tablets.
    Čapková-Helešicová T, Pekárek T, Schöngut M, Matějka P.
    J Pharm Biomed Anal; 2019 May 10; 168():113-123. PubMed ID: 30802750
    [Abstract] [Full Text] [Related]

  • 9. Dissolution or disintegration - substitution of dissolution by disintegration testing for a fixed dose combination product.
    Grube A, Gerlitzki C, Brendel M.
    Drug Dev Ind Pharm; 2019 Jan 10; 45(1):130-138. PubMed ID: 30230388
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of neurofuzzy logic and decision trees in discovering knowledge from experimental data of an immediate release tablet formulation.
    Shao Q, Rowe RC, York P.
    Eur J Pharm Sci; 2007 Jun 10; 31(2):129-36. PubMed ID: 17459671
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Quality surveillance of immediate release aceclofenac tablets (100 mg) available in local market.
    Bushra R, Shoaib MH, Ali H, Shafiq Y, Zafar F, Alam S, Aslam N.
    Pak J Pharm Sci; 2017 Nov 10; 30(6):2193-2201. PubMed ID: 29175789
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Linking dissolution to disintegration in immediate release tablets using image analysis and a population balance modelling approach.
    Wilson D, Wren S, Reynolds G.
    Pharm Res; 2012 Jan 10; 29(1):198-208. PubMed ID: 21833795
    [Abstract] [Full Text] [Related]

  • 18. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
    Zaheer K, Langguth P.
    Eur J Pharm Biopharm; 2019 Jun 10; 139():177-185. PubMed ID: 30902732
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.